Editorial
doi: 10.1001/archopht.119.7.1067.
Fifteen years of work: the COMS outcomes for medium-sized choroidal melanoma
- PMID: 11448330
- DOI: 10.1001/archopht.119.7.1067
Item in Clipboard
Editorial
Fifteen years of work: the COMS outcomes for medium-sized choroidal melanoma
Arch Ophthalmol.
2001 Jul.
No abstract available
Comment on
-
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.Arch Ophthalmol. 2001 Jul;119(7):951-65. doi: 10.1001/archopht.119.7.951. Arch Ophthalmol. 2001. PMID: 11448318 Clinical Trial.
-
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.Arch Ophthalmol. 2001 Jul;119(7):969-82. doi: 10.1001/archopht.119.7.969. Arch Ophthalmol. 2001. PMID: 11448319 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
